Poisonous metal compounds
|
Toxic doses
|
Rat
|
2.5<Toxic doseRat/Toxic doseHuman<152
|
[31]
|
| | |
Geometric mean (GM) = 12
| |
18 chemotherapeutical agents
|
Lethal Dose (LD)10 and Maximum Tolerated Dose (MTD)
|
Mouse, rat, hamster, dog, monkey
|
LD10 (mg/m2)/3 carries 5.9% probability of exceeding MTDHuman
|
[62, 63]
|
10 pesticides (single dose) and 12 pesticides (repeated doses)
|
Various toxic doses
|
Rat, dog, pig, calf, cow, horse, sheep, steer
|
1.9<Acute non fatal doseAnimal/Acute non fatal doseHuman<100
|
[31, 64]
|
| | |
GM = 11.
| |
| | |
0.58 <Chronic doseAnimal/Chronic doseHuman<9.4
| |
| | |
GM = 2.9.
| |
40 anticancer agents
|
MTD
|
Dogs, monkeys
|
MTD/10 carries a clinical risk human toxicity of 3% (3 out of every 100 drugs)
|
[65]
|
107 pharmaceuticals (?)
|
Toxicity indices
|
4 to 6 laboratory animal species
|
Extrapolation of doses (mg/kg) from white rats to man exaggerated tolerable dose 5.5- to 40-fold
|
[66]
|
25 chemotherapeutic agents
|
LD10 and MTD
|
Mouse, rat, hamster, dog, monkey
|
The predicted MTDHuman is overestimated for 20% of agents using 0.75 power (caloric demand) scaling, less with body surface scaling
|
[52]
|
26 pharmaceuticals
|
Maximum therapeutic equivalent dose and toxicokinetic parameters
|
Up to 4 laboratory animal species
|
Scaling according to metabolic rate underestimated risk to man in 59% of cases
|
[67]
|
63 anti-neoplastic drugs
|
LD10, Toxic Dose Low (TDL) and MTD
|
Rat, mouse, hamster, dog, monkey
|
LD10 or TDLMouse/MTDhuman = 8.0 (P95 = 50.9)
|
[68]
|
| | |
LD10 or TDLHamster/MTDhuman = 7.6 (P95 = 52.1)
| |
| | |
LD10 or TDLRat/MTDhuman = 2.6 (P95 = 21.7)
| |
| | |
LD10 or TDLMonkey/MTDhuman = 2.4 (P95 = 15.3)
| |
| | |
LD10 or TDLDog/MTDhuman = 1.2 (P95 = 7.0)
| |
61 anti-neoplastic drugs
|
LD10 and MTD
|
Mouse, rat, dog, monkey
|
LD10Mouse /MTDHuman >10 for 37% compounds
|
[69]
|
| | |
LD10Rat /MTDHuman >10 for 19% compounds
| |
| | |
LD10Monkey /MTDHuman >10 for 5% compounds
| |
| | |
LD10Dog/MTDHuman >10 for 3% compounds
| |